Indies Pharma Jamaica Limited reported earnings results for the first quarter ended January 31, 2024. For the first quarter, the company reported sales was JMD 269.38 million compared to JMD 255.64 million a year ago. Net income was JMD 62.49 million compared to JMD 59.03 million a year ago.

Basic earnings per share from continuing operations was JMD 0.047 compared to JMD 0.045 a year ago.